Q9NYB0 (TE2IP_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 117.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Telomeric repeat-binding factor 2-interacting protein 1 Short name=TERF2-interacting telomeric protein 1 Short name=TRF2-interacting telomeric protein 1 Alternative name(s): Dopamine receptor-interacting protein 5 Repressor/activator protein 1 homolog Short name=RAP1 homolog Short name=hRap1 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 399 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Acts both as a regulator of telomere function and as a transcription regulator. Involved in the regulation of telomere length and protection as a component of the shelterin complex (telosome). In contrast to other components of the shelterin complex, it is dispensible for telomere capping and does not participate in the protection of telomeres against non-homologous end-joining (NHEJ)-mediated repair. Instead, it is required to negatively regulate telomere recombination and is essential for repressing homology-directed repair (HDR), which can affect telomere length. Does not bind DNA directly: recruited to telomeric double-stranded 5'-TTAGGG-3' repeats via its interaction with TERF2. Independently of its function in telomeres, also acts as a transcription regulator: recruited to extratelomeric 5'-TTAGGG-3' sites via its association with TERF2 or other factors, and regulates gene expression. When cytoplasmic, associates with the I-kappa-B-kinase (IKK) complex and acts as a regulator of the NF-kappa-B signaling by promoting IKK-mediated phosphorylation of RELA/p65, leading to activate expression of NF-kappa-B target genes. Ref.12 Ref.20 |
| Subunit structure | Associates with the I-kappa-B-kinase (IKK) core complex, composed of CHUK, IKBKB and IKBKG By similarity. Homodimer. Component of the shelterin complex (telosome) composed of TERF1, TERF2, TINF2, TERF2IP ACD and POT1. Interacts with TERF2; the interaction is direct. Does not interact with TERF1. Interacts with SLX4/BTBD12. Ref.19 |
| Subcellular location | Nucleus. Cytoplasm By similarity. Chromosome. Chromosome › telomere. Note: Associates with chromosomes, both at telomeres and in extratelomeric sites. Also exists as a cytoplasmic form, where it associates with the IKK complex By similarity. |
| Tissue specificity | Ubiquitous. Highly expressed. |
| Post-translational modification | Phosphorylated upon DNA damage, probably by ATM or ATR. Ref.11 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.18 Ref.21 |
| Miscellaneous | Shares a bidirectional promoter with KARS (Ref.8). |
| Sequence similarities | Belongs to the RAP1 family. Contains 1 BRCT domain. Contains 1 Myb-like domain. |
| Caution | Was reported to participate in the protection of telomeres against non-homologous end-joining (NHEJ)-mediated repair in the absence of TERF2 (Ref.20). However this probably does not corresponds to its primary function and experiments in mouse showed that it is dispensible for such process and is required for repressiion of homology-directed repair (HDR). |
| Sequence caution | The sequence AAL55783.1 differs from that shown. Reason: Frameshift at position 151. The sequence BAA91317.1 differs from that shown. Reason: Erroneous termination at position 299. Translated as Glu. The sequence BAG60996.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| SLX4 | Q8IY92 | 4 | EBI-750109,EBI-2370740 | |
| TERF2 | Q15554 | 5 | EBI-750109,EBI-706637 | |
| TINF2 | Q9BSI4-3 | 3 | EBI-750109,EBI-717418 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||
Molecule processing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed | ||||||||||||||||
| Chain | 2 – 399 | 398 | Telomeric repeat-binding factor 2-interacting protein 1 | PRO_0000197126 | |||||||||||||||
Regions | |||||||||||||||||||
| Domain | 78 – 101 | 24 | BRCT | ||||||||||||||||
| Domain | 128 – 188 | 61 | Myb-like | ||||||||||||||||
| Motif | 383 – 399 | 17 | Nuclear localization signal Potential | ||||||||||||||||
| Compositional bias | 214 – 304 | 91 | Asp/Glu-rich (acidic) | ||||||||||||||||
Amino acid modifications | |||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.18 | ||||||||||||||||
| Modified residue | 36 | 1 | Phosphoserine Ref.17 | ||||||||||||||||
| Modified residue | 154 | 1 | Phosphoserine Ref.11 Ref.13 Ref.17 Ref.21 | ||||||||||||||||
| Modified residue | 156 | 1 | Phosphoserine Ref.13 | ||||||||||||||||
| Modified residue | 203 | 1 | Phosphoserine Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.18 Ref.21 | ||||||||||||||||
| Modified residue | 205 | 1 | Phosphoserine Ref.18 | ||||||||||||||||
| Modified residue | 206 | 1 | Phosphoserine Ref.15 | ||||||||||||||||
Natural variations | |||||||||||||||||||
| Natural variant | 324 | 1 | K → E. Corresponds to variant rs4888444 [ dbSNP | Ensembl ]. | VAR_050195 | |||||||||||||||
Experimental info | |||||||||||||||||||
| Sequence conflict | 83 | 1 | Y → H in BAA91317. Ref.4 | ||||||||||||||||
Secondary structure | |||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||
| Helix | 138 – 150 | 13 | |||||||||||||||||
| Turn | 155 – 159 | 5 | |||||||||||||||||
| Helix | 162 – 169 | 8 | |||||||||||||||||
| Beta strand | 172 – 174 | 3 | |||||||||||||||||
| Helix | 178 – 187 | 10 | |||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of human RAP1: implications for telomere evolution." Li B., Oestreich S., de Lange T. Cell 101:471-483(2000) [PubMed: 10850490] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Cervix carcinoma. |
| [2] | "Cloning and characterization of DRIP5, a new protein that specifically interacts with the D1 dopamine receptor." Lafuente M.J., Nasir J. Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Large-scale cDNA transfection screening for genes related to cancer development and progression." Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X. Gu J.Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004) [PubMed: 15498874] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Ileal mucosa and Teratocarcinoma. |
| [5] | "The sequence and analysis of duplication-rich human chromosome 16." Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J. Pennacchio L.A.Nature 432:988-994(2004) [PubMed: 15616553] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Colon, Lung and Skin. |
| [8] | "The telomeric protein Rap1 is conserved in vertebrates and is expressed from a bidirectional promoter positioned between the Rap1 and KARS genes." Tan M., Wei C., Price C.M. Gene 323:1-10(2003) [PubMed: 14659874] [Abstract] Cited for: BIDIRECTIONAL PROMOTER WITH KARS. |
| [9] | "TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres." Ye J.Z.-S., Donigian J.R., van Overbeek M., Loayza D., Luo Y., Krutchinsky A.N., Chait B.T., de Lange T. J. Biol. Chem. 279:47264-47271(2004) [PubMed: 15316005] [Abstract] Cited for: IDENTIFICATION IN THE SHELTERIN COMPLEX. |
| [10] | "Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins." Liu D., O'Connor M.S., Qin J., Songyang Z. J. Biol. Chem. 279:51338-51342(2004) [PubMed: 15383534] [Abstract] Cited for: IDENTIFICATION IN THE SHELTERIN COMPLEX. |
| [11] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Shelterin: the protein complex that shapes and safeguards human telomeres." de Lange T. Genes Dev. 19:2100-2110(2005) [PubMed: 16166375] [Abstract] Cited for: FUNCTION OF THE SHELTERIN COMPLEX. |
| [13] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154; SER-156 AND SER-203, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [15] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-206, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [16] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-154 AND SER-203, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND SER-205, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [19] | "Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair." Svendsen J.M., Smogorzewska A., Sowa M.E., O'Connell B.C., Gygi S.P., Elledge S.J., Harper J.W. Cell 138:63-77(2009) [PubMed: 19596235] [Abstract] Cited for: INTERACTION WITH SLX4. |
| [20] | "Human RAP1 inhibits non-homologous end joining at telomeres." Sarthy J., Bae N.S., Scrafford J., Baumann P. EMBO J. 28:3390-3399(2009) [PubMed: 19763083] [Abstract] Cited for: FUNCTION. |
| [21] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154 AND SER-203, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [22] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [23] | "NMR structure of the hRap1 Myb motif reveals a canonical three-helix bundle lacking the positive surface charge typical of Myb DNA-binding domains." Hanaoka S., Nagadoi A., Yoshimura S., Aimoto S., Li B., de Lange T., Nishimura Y. J. Mol. Biol. 312:167-175(2001) [PubMed: 11545594] [Abstract] Cited for: STRUCTURE BY NMR OF 132-190. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF262988 mRNA. Translation: AAF72711.1. AF250393 mRNA. Translation: AAQ14259.1. AF289599 mRNA. Translation: AAL55783.1. Frameshift. AK000669 mRNA. Translation: BAA91317.1. Sequence problems. AK298880 mRNA. Translation: BAG60996.1. Different initiation. AC025287 Genomic DNA. No translation available. CH471114 Genomic DNA. Translation: EAW95616.1. CH471114 Genomic DNA. Translation: EAW95618.1. BC004465 mRNA. Translation: AAH04465.1. BC005841 mRNA. Translation: AAH05841.1. BC022428 mRNA. Translation: AAH22428.1. BC078171 mRNA. Translation: AAH78171.1. | ||||||||||||||||||
| IPI | IPI00008961. | ||||||||||||||||||
| RefSeq | NP_061848.2. NM_018975.3. | ||||||||||||||||||
| UniGene | Hs.301419. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q9NYB0. | ||||||||||||||||||
| SMR | Q9NYB0. Positions 17-101, 132-190, 306-398. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP-34868N. | ||||||||||||||||||
| IntAct | Q9NYB0. 14 interactions. | ||||||||||||||||||
| MINT | MINT-1454139. | ||||||||||||||||||
| STRING | Q9NYB0. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q9NYB0. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 21542267. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PeptideAtlas | Q9NYB0. | ||||||||||||||||||
| PRIDE | Q9NYB0. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000300086; ENSP00000300086; ENSG00000166848. | ||||||||||||||||||
| GeneID | 54386. | ||||||||||||||||||
| KEGG | hsa:54386. | ||||||||||||||||||
| UCSC | uc002fet.1. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 54386. | ||||||||||||||||||
| GeneCards | GC16P075681. | ||||||||||||||||||
| H-InvDB | HIX0013251. | ||||||||||||||||||
| HGNC | HGNC:19246. TERF2IP. | ||||||||||||||||||
| HPA | CAB018660. CAB018749. HPA006719. | ||||||||||||||||||
| MIM | 605061. gene. | ||||||||||||||||||
| neXtProt | NX_Q9NYB0. | ||||||||||||||||||
| PharmGKB | PA134976325. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| GeneTree | ENSGT00390000005351. | ||||||||||||||||||
| HOGENOM | HBG713232. | ||||||||||||||||||
| HOVERGEN | HBG054209. | ||||||||||||||||||
| InParanoid | Q9NYB0. | ||||||||||||||||||
| OMA | HGGGTVC. | ||||||||||||||||||
| OrthoDB | EOG4K6G59. | ||||||||||||||||||
| PhylomeDB | Q9NYB0. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | telomerasepathway. Regulation of Telomerase. | ||||||||||||||||||
| Reactome | REACT_111183. Meiosis. REACT_22172. Chromosome Maintenance. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q9NYB0. | ||||||||||||||||||
| Bgee | Q9NYB0. | ||||||||||||||||||
| CleanEx | HS_TERF2IP. | ||||||||||||||||||
| Genevestigator | Q9NYB0. | ||||||||||||||||||
| GermOnline | ENSG00000166848. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR009057. Homeodomain-like. IPR012287. Homeodomain-rel. IPR015010. Myb_DNA-bd_2. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:1.10.10.60. Homeodomain-rel. 1 hit. | ||||||||||||||||||
| KO | K11113. | ||||||||||||||||||
| Pfam | PF08914. Myb_DNA-bind_2. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF46689. Homeodomain_like. 1 hit. | ||||||||||||||||||
| PROSITE | PS50172. BRCT. False negative. PS50090. MYB_LIKE. False negative. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| NextBio | 56609. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | TE2IP_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NYB0 Secondary accession number(s): B4DQN4 Q9NWR2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with